
all things biotech and natsec 🧬. former @CSETGeorgetown, @CWRUSOM. cleveland forever. views my own
Joined February 2011
- Tweets467
- Following1.1K
- Followers340
- Likes2.7K
Caroline Schuerger retweeted
🧬New Report 🧬
How has China prioritized collecting biological data, and what are the #medicalAI and #bioeconomy implications?
@VikramVenkatram, @clschuerger, and Katherine Quinn explore China’s biodata collection efforts. Read more here ⬇️ cset.georgetown.edu/publicat…
Happy to share my last publication from my time at CSET!
🧬New Report 🧬
How has China prioritized collecting biological data, and what are the #medicalAI and #bioeconomy implications?
@VikramVenkatram, @clschuerger, and Katherine Quinn explore China’s biodata collection efforts. Read more here ⬇️ cset.georgetown.edu/publicat…
9
330
Some of my last work from CSET is in print! Great working with @steph_batalis, @ggronvall, and Matt E. Walsh on the opportunities and challenges of the AI x Synthetic Bio convergence!
Sharing my new article in Applied Biosafety with Stephanie Batalis, Caroline Schuerger @clschuerger, and Matt E. Walsh on "Safeguarding Mail-Order DNA Synthesis in the Age of Artificial Intelligence."
liebertpub.com/doi/epub/10.1…
Caroline Schuerger retweeted
Sharing my new article in Applied Biosafety with Stephanie Batalis, Caroline Schuerger @clschuerger, and Matt E. Walsh on "Safeguarding Mail-Order DNA Synthesis in the Age of Artificial Intelligence."
liebertpub.com/doi/epub/10.1…
Caroline Schuerger retweeted
Much is misunderstood about gain-of-function research, and without taking a nuanced look at the issue, one-size-fits-all restrictions will do more harm than good, argue CSET's @steph_batalis + @clschuerger via @CFR_org's @ThinkGlobalHlth. Read more here ⬇️ thinkglobalhealth.org/articl…
Great thread by my coauthor and colleague @steph_batalis. Check out the rest of our report here: cset.georgetown.edu/publicat…
Replying to @steph_batalis
The main takeaway? Two things can be true at once: GOF/LOF research can be important for science and medicine while a subset can also be risky if conducted improperly. Differentiating between the two will require nuanced and careful policy.
Caroline Schuerger retweeted
First global survey reveals who is doing ‘gain of function’ research on pathogens and why go.nature.com/3LniesE
Thank you @maxdkozlov for covering our latest project on gain of function research!
The labs studying pathogens' new tricks: who is doing 'gain of function' work and why?
A new @CSETGeorgetown report gives hard numbers on where GOF is happening and on which pathogens
In @Nature w/ @AnnaPuglisi838 @ggronvall @GoodrumVirusLab @clschuerger
nature.com/articles/d41586-0…
5
170
Caroline Schuerger retweeted
Proud of all the work that went into this report, and glad it’s finding its way to a wider audience! This is just the tip of the iceberg - but it’s important to know what kind of research is happening on a large scale.
The labs studying pathogens' new tricks: who is doing 'gain of function' work and why?
A new @CSETGeorgetown report gives hard numbers on where GOF is happening and on which pathogens
In @Nature w/ @AnnaPuglisi838 @ggronvall @GoodrumVirusLab @clschuerger
nature.com/articles/d41586-0…
Caroline Schuerger retweeted
Why do researchers make pathogens more infectious? In our new report, we find that gain- and loss-of-function #research is widely used to develop new #vaccines or study pathogens that cause a high #GlobalHealth burden, like flu viruses. Read more: cset.georgetown.edu/publicat…
Caroline Schuerger retweeted
Important perspective from Hopkins' Matt E. Walsh: "large language model-based chatbots and bio-design tools influence the biosecurity landscape in vastly different ways. Their governance, therefore, should be considered and developed independently."
thebulletin.org/2023/09/why-…
Our latest report adds additional insight into the gain-of-function discussion: we used machine learning to map and characterize approximately 7,000 scientific publications that use gain-or loss-of-function and discusses the regulatory opportunities and challenges
✨New Policy Brief✨
When it comes to regulating ‘risky’ gain of function research, one size does not fit all. Check out our new report describing the scale of this research + details on the range of methodologies, pathogens + public health applications. cset.georgetown.edu/publicat…
Caroline Schuerger retweeted
Gain-of-function research: what is it? How and why do researchers do it? What does the research landscape look like?
So proud to be part of this report where we answer these questions and more using ~7,000 examples of gain- or loss-of-function research!
✨New Policy Brief✨
When it comes to regulating ‘risky’ gain of function research, one size does not fit all. Check out our new report describing the scale of this research + details on the range of methodologies, pathogens + public health applications. cset.georgetown.edu/publicat…
Caroline Schuerger retweeted
Drug discovery💊, unraveling the mystery of genetics🧬, and redefining precision medicine🎯are ALL being helped by the newly unleashed 💥power💥of #AI. Dive in @steph_batalis, @clschuerger, and @VikramVenkatram's summary to learn more!🔍🚀
cset.georgetown.edu/article/…
Caroline Schuerger retweeted
I signed my name in support of the bipartisan #DiseaseX Act of 2023 because the US needs sustained federal funding to prepare for unknown threats. Glad to see this legislature moving forward!
🏛 Today, we applaud the #bipartisan introduction of the #DiseaseX Act of 2023.
Thank you for your leadership on this important #pandemicpreparedness bill, @RepLoriTrahan, @DrBurgessTX, @DanCrenshawTX, and @RepSusieLee!
bit.ly/3NcQEzU
Caroline Schuerger retweeted
As we consider the future of LLMs in bio and medicine, the (very real!) discussion of risk needs to be balanced with the ways that LLMs already power health applications.
Check out my newest blog post below with @clschuerger and @VikramVenkatram!⬇️
🔬New blog post🧪
LLMs are already helping scientists perform important tasks. @steph_batalis, @clschuerger & @VikramVenkatram explore three areas in the life sciences where LLMs are catalyzing advances: drug discovery, genetics, and precision medicine. cset.georgetown.edu/article/…
Check my new blog post with CSET's @emergingtechobs where I explore global trends in research on AI + genetics!
✨New blog post✨ AI + genetics research - who's ahead, and who's catching up... eto.tech/blog/exploring-tren…
Caroline Schuerger retweeted
What does it mean to have a resilient biomanufacturing ecosystem for U.S. national security? Check out my latest report at @CSETGeorgetown ⬇️💉
#biomanufacturing #bioeconomy #biosecurity
💉New Policy Brief💉
Vaccines are a key aspect of U.S. national security, public health, biosecurity, and pandemic preparedness. But CSET's @steph_batalis and @AnnaPuglisi838 find that the 🇺🇸 vaccine supply is vulnerable. Here's what needs to be done: cset.georgetown.edu/publicat…
BIG piece from the bio team!! Building off our previous work, this paper highlights vulnerabilities of vaccine manufacturing in the U.S.
💉New Policy Brief💉
Vaccines are a key aspect of U.S. national security, public health, biosecurity, and pandemic preparedness. But CSET's @steph_batalis and @AnnaPuglisi838 find that the 🇺🇸 vaccine supply is vulnerable. Here's what needs to be done: cset.georgetown.edu/publicat…
9
369










